-
'Where is she?' The desperate search for Venezuela's missing
-
Former Barca teen star Fati seals permanent Monaco switch
-
No business as usual after shock World Cup exit, say German FA
-
German rail regulator backs Italian firm in competition spat
-
Pope appeals to Catholic traditionalists to avoid schism
-
Ancelotti shows Brazil his worth at World Cup but concerns remain
-
US Supreme Court upholds transgender sports bans
-
Stocks rise, yen at 40-year low against dollar
-
US Supreme Court rejects Trump bid to restrict birthright citizenship
-
Australia hold West Indies to 125-7 in World Cup semi-final
-
Serena set for remarkable Wimbledon return, Swiatek survives scare
-
Defending champ Swiatek survives scare to reach Wimbledon second round
-
Africa EV firm Spiro accused of torturing Uganda employees
-
US Supreme Court upholds state bans on transgender athletes in school
-
PSG's Portugal forward Ramos signs five-year AC Milan deal
-
Tourists soldier on in Rome despite heatwave
-
Inflation slows in top eurozone economies as ECB ponders next move
-
Record number of 'new millionaires' in 2025, says UBS
-
Starmer boosts budget to modernise UK military before exit
-
UN calls for food, shelter to help Venezuela quake survivors
-
Stocks mostly higher, yen stays near 40-year low against dollar
-
Merz faces mockery over praise of Germany's World Cup team
-
Data centres emitting more CO2 than thought: study
-
Ride-share group BlaBlaCar taps AI for 20-country expansion
-
Over 1 million migrants apply for Spain's mass regularisation
-
Escaping heat, forgetting war: Kyiv locals hit the beach
-
Germany questions footballing identity after fresh World Cup failure
-
Thousands march to demand illegal migrants leave South Africa
-
MEXC Lists Ondo's Tokenized Strategy Preferred Stock on Spot Market
-
Serena set for remarkable Wimbledon return
-
Stocks climb, yen stays near 40-year low against dollar
-
Outgoing UK PM Starmer announces 'record' defence spending
-
Swim star Marchand limps out of French nationals as Europeans loom
-
Paralluelo joins Barca women's departures
-
UN says transport infrastructure must adapt to climate
-
Police hunt for Monaco bomb suspect after Ukrainian-born businessman wounded
-
Sommer, Acerbi, Darmian, De Vrij leave Inter Milan
-
Sommer, Acerbi, Darmian leave Inter Milan
-
Germany's labour market dilemma: rising unemployment despite vacancies
-
'Waiting like torture': Turks despair as Schengen visa delays mount
-
Skating allows Russian, Belarussians to return as neutrals
-
Venezuela rescuers in final push to find survivors as families mourn
-
Russian double Olympic figure skating champion Dmitriev dies aged 58
-
Over 1 million migrants apply for Spain's mass regularisation: PM
-
S. Africa deploys police as anti-migrant protests loom
-
Thousands from Philippine sect protest pro-Duterte senator's graft case
-
Monaco parcel bomb blast wounds Ukrainian oligarch
-
South Africa repatriations top 25,000 ahead of anti-immigrant ultimatum
-
Sweden face France's attacking firepower at the World Cup
-
Taiwan raids tech firms in China AI chip smuggling probe
Viruses that could save millions of lives
It may seem strange after a pandemic that has killed millions and turned the world upside down, but viruses could save just as many lives.
In a petri dish in a laboratory in the Georgian capital Tbilisi, a battle is going on between antibiotic resistant bacteria and "friendly" viruses.
This small nation in the Caucasus has pioneered research on a groundbreaking way to tackle the looming nightmare of bacteria becoming resistant to the antibiotics on which the world depends.
Long overlooked in the West, bacteriophages or bacteria-eating viruses are now being used on some of the most difficult medical cases, including a Belgian woman who developed a life-threatening infection after being injured in the 2016 Brussels airport bombing.
After two years of unsuccessful antibiotic treatment, bacteriophages sent from Tbilisi cured her infection in three months.
"We use those phages that kill harmful bacteria" to cure patients when antibiotics fail, Mzia Kutateladze of the Eliava Institute of Bacteriophages told AFP.
Even a banal infection can "kill a patient because the pathogen has developed resistance to antibiotics," Kutateladze said.
In such cases, phagotherapy "is one of the best alternatives", she added.
Phages have been known about for a century, but were largely forgotten and dismissed after antibiotics revolutionised medicine in the 1930s.
- Stalin's henchman -
It didn't help that the man who did most to develop them, Georgian scientist Giorgi Eliava, was executed in 1937 on the orders of another Georgian, Lavrentiy Beria, Stalin's most notorious henchman and the head of his secret police.
Eliava had worked in the Pasteur Institute in Paris with French-Canadian microbiologist Felix d'Herelle, one of the two men credited with discovering phages, and persuaded Stalin to invite him to Tbilisi in 1934.
But their collaboration was cut short when Beria had Eliava killed, although his motive still remains a mystery.
With the World Health Organization now declaring antimicrobial resistance a global health crisis, phages are making a comeback, especially as they can target bacteria while leaving human cells intact.
A recent study warned that superbugs could kill as many as 10 million people a year when antimicrobial resistance due to overuse of antibiotics reaches a tipping point. That could come within three decades.
- 'Training' viruses -
While phages-based medicines cannot completely replace antibiotics, researchers say they have major pluses in being cheap, not having side-effects nor damaging organs or gut flora.
"We produce six standard phages that are of wide spectrum and can heal multiple infectious diseases," said Eliava Institute physician Lia Nadareishvili.
In some 10 to 15 percent of patients, however, standard phages don't work and "we have to find ones capable of killing the particular bacterial strain," she added.
Tailored phages to target rare infections can be selected from the institute's massive collection -- the world's richest -- or be found in sewage or polluted water or soil, Kutateladze said.
The institute can even "train" phages so that "they can kill more and more different harmful bacteria."
"It is a cheap and easily accessible therapy," she added.
- Last-resort treatment -
A 34-year-old American mechanical engineer suffering from a chronic bacterial disease for six years told AFP he "already felt improvement" after two weeks at the Tbilisi institute.
"I've tried every possible treatment in the United States," said Andrew, who would only give his first name.
He is one of the hundreds of patients from around the globe who arrive in Georgia every year for last-resort treatment, said Nadareishvili.
With the traditional antimicrobial armoury depleting rapidly, more clinical studies are needed so that phagotherapy can be more widely approved, Kutateladze argued.
In 2019, the United States Food and Drug Administration (FDA) authorised a clinical study on the use of bacteriophages to cure secondary infections in Covid patients.
Beyond medicine, phages are already being used to stop food going off, and they "can be used in agriculture to protect crops and animals from harmful bacteria," Kutateladze said.
The institute has already conducted research on bacteria targeting cotton and rice.
Bacteriophages also have potential to counter biological weapons and combat bioterrorism, with Canadian researchers publishing a 2017 study on using them to counter an anthrax attack on crowded public places.
C.Meier--BTB